7Baggers
Quarterly
Annual
    Unit: USD2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2012-03-31 
      
    		                     
      cash flows from operating activities:
    		                     
      net income
    		23,316,000 -18,767,000 -28,882,000 33,036,000 45,062,000 -449,956,000 54,421,000 67,678,000 56,210,000 66,241,000 62,548,000 67,428,000 -13,567,000 16,614,000 52,482,000 54,555,000 82,962,000 139,911,000 123,900,000 109,893,000 47,403,000 
      adjustments required to reconcile net income to net cash from operating activities:
    		                     
      depreciation and amortization
    		6,449,000 6,346,000 6,343,000 5,976,000 5,790,000 5,571,000 5,282,000 5,447,000 5,583,000 5,071,000 4,516,000 4,299,000 2,758,000 4,228,000 4,019,000 3,775,000 3,762,000 3,670,000 3,705,000 3,692,000 4,598,000 
      realized loss on sale of long-lived assets
    		                     
      change in derivative instruments
    		-148,000 -166,000 154,000 552,000 -19,000 -923,000 746,000 -637,000 -337,000 -2,421,000 -1,020,000 3,546,000 -6,774,000 -253,000 -1,295,000 -3,093,000 -3,067,000 2,164,000 -334,000 2,671,000 -3,392,000 
      effect of exchange differences on intercompany balances
    		                     
      foreign exchange effect of marketable securities and bank deposits
    		                     
      adjustments to opening balance sheet
    		                     
      deferred income taxes
    		5,683,000 11,244,000 -6,536,000 7,714,000 -37,224,000 -2,367,000 9,660,000 -2,378,000 -2,628,000 2,930,000 -3,280,000 1,575,000 55,266,000 45,727,000 10,988,000 4,825,000 86,844,000 -1,716,000 8,860,000 -20,282,000 4,075,000 
      decrease (increase) in trade receivables
    		      -7,894,000   24,431,000    3,838,000 -15,404,000 18,270,000     9,879,000 
      increase in other receivables, prepaid expenses and other
    		                    -535,000 
      increase in inventories
    		-68,000 -2,568,000 -10,765,000 -2,314,000 -990,000 -13,150,000 4,802,000 -9,436,000 -155,000 -205,000   4,817,000 725,000 -3,872,000 -2,114,000 5,350,000 2,491,000 -2,421,000 -9,190,000 -1,583,000 
      decrease (increase) in income tax receivables
    		                     
      increase in trade payables
    		                    -521,000 
      increase in other accounts payable and accrued expenses
    		                    3,241,000 
      increase in income tax payables
    		                    12,138,000 
      expense from amortization of marketable securities bonds
    		3,108,000 2,179,000                    
      net cash from operating activities
    		-52,016,000 43,993,000 51,055,000 42,862,000 -112,257,000 64,110,000 49,597,000 98,650,000 40,754,000 82,604,000 75,210,000 82,440,000 58,560,000 87,098,000 66,029,000 72,668,000 117,080,000 127,778,000 136,712,000 55,965,000 78,094,000 
      capex
    		-523,000 1,225,000 2,544,000 -957,000 106,000 1,304,000 -2,000 -521,000 -317,000 2,317,000 435,000 1,823,000 737,000 655,000 -445,000 1,180,000 338,000 0 0 0 -977,000 
      free cash flows
    		-52,539,000 45,218,000 53,599,000 41,905,000 -112,151,000 65,414,000 49,595,000 98,129,000 40,437,000 84,921,000 75,645,000 84,263,000 59,297,000 87,753,000 65,584,000 73,848,000 117,418,000 127,778,000 136,712,000 55,965,000 77,117,000 
      cash flows from investing activities:
    		                     
      purchase of property, plant and equipment
    		                    -1,610,000 
      investment in other intangible assets
    		-35,000 -72,000 -44,000 -41,000 -13,000 -63,000 -767,000 -971,000 -15,000 -30,000 -1,049,000 -45,000 19,000  502,000 -2,056,000   -11,000 -11,000  
      investment in short-term bank deposits
    		                     
      investment in marketable securities
    		 -12,500,000    -40,825,000   -107,424,000 -9,070,000 -51,391,000 -107,644,000         -4,909,000 
      proceeds from marketable securities
    		                     
      (investment in) proceeds from acquisitions and sale of long-lived assets
    		                     
      cash acquired from acquisition
    		                     
      net cash from investing activities
    		-31,526,000 -16,427,000 21,946,000 13,004,000 78,812,000 -46,021,000 -44,403,000 -123,617,000 -113,073,000 -17,069,000 115,635,000 8,263,000 -540,373,000 -6,732,000 37,225,000 -234,801,000 -41,689,000 86,539,000 -100,764,000 -61,864,000 15,586,000 
      cash flows from financing activities:
    		                     
      repurchase of treasury stock
    		                     
      net cash from financing activities
    		-6,615,000 -18,319,000 -20,953,000    -157,000    -7,749,000 -24,655,000 465,205,000 -14,504,000 -31,928,000 -8,489,000 -25,185,000 -29,094,000 -108,129,000 -132,489,000 -6,588,000 
      effect of exchange rate changes on cash and cash equivalents
    		-1,063,000 464,000 211,000 1,499,000 197,000 601,000 -1,044,000    515,000 -670,000 2,962,000 10,000 1,282,000 936,000 547,000 -1,215,000 -913,000 363,000 1,173,000 
      increase in cash and cash equivalents
    		 9,711,000 52,259,000   18,690,000   -72,319,000 65,535,000 183,611,000 65,378,000     50,753,000    88,265,000 
      cash and cash equivalents at the beginning of the period
    		                    150,001,000 
      cash and cash equivalents at the end of the period
    		                    238,266,000 
      supplemental disclosure of cash flow transactions:
    		                     
      cash paid during the year for:
    		                     
      income taxes
    		1,199,000 3,333,000 5,208,000 3,573,000 13,477,000 7,119,000 15,763,000 16,932,000 11,409,000 10,432,000 5,151,000 36,830,000 3,564,000 2,409,000 10,588,000 29,595,000     1,039,000 
      cash received during the year for:
    		                     
      non-cash investing transactions:
    		                     
      purchase of property, plant and equipment included in accounts payable
    		-523,000 1,225,000 2,544,000 -957,000 106,000 1,304,000 -2,000 -521,000 -317,000 2,317,000 435,000 1,823,000 737,000 655,000 -445,000 1,180,000 338,000     
      adjustment to purchase price
    		                     
      investment in intangible assets on credit
    		                     
      non-cash financing transactions:
    		                     
      purchase of treasury stock
    		-6,615,000 -18,319,000 -20,953,000        -7,749,000 -24,655,000 -34,795,000 -14,504,000 -31,928,000 -8,489,000  -29,094,000 -108,129,000 -132,489,000  
      purchase of marketable securities
    		        8,153,000 2,436,000 -2,539,000 8,629,000 1,692,000         
      realized losss on sale of long-lived assets
    		                     
      effect of change in exchange rate on marketable securities and bank deposits
    		993,000 -589,000                    
      increase in trade receivables
    		 -3,295,000         -14,627,000 -2,897,000 16,142,000     -2,126,000 39,935,000 -51,220,000  
      decrease (increase) in other receivables, income tax receivables, prepaid expenses and other
    		                     
      decrease in trade, income tax, accrued expenses and other payables
    		                     
      purchase of plant, property & equipment
    		-1,976,000 -3,855,000 -2,773,000 -5,257,000 -3,820,000 -5,133,000  -5,747,000 -5,634,000 -7,969,000 -6,057,000 -6,078,000 -7,360,000 -5,933,000 -7,252,000 -4,557,000  -7,139,000 -10,054,000 -9,184,000  
      proceeds from (investment in) marketable securities
    		  24,763,000 18,302,000              15,000 0 80,000  
      decrease in cash and cash equivalents
    		      3,993,000       65,872,000 72,608,000 -169,686,000   -73,094,000 -138,025,000  
      cash and cash equivalents at beginning of period
    		0 605,177,000 0 0 0 513,354,000  0 0 567,451,000 0 576,611,000 23,788,000 0 0 600,399,000  0 0 576,757,000  
      cash and cash equivalents at end of period
    		-91,220,000 614,888,000 52,259,000 54,122,000 -33,248,000 532,044,000  -51,306,000 -72,319,000 632,986,000 183,611,000 641,989,000 10,142,000 65,872,000 72,608,000 430,713,000  184,008,000 -73,094,000 438,732,000  
      increase in income tax receivables
    		                     
      (investment in) proceeds from acquisitions, net of sale of long-lived assets
    		                     
      decrease in trade receivables
    		  15,288,000   45,921,000                
      increase in other receivables, income tax receivables, prepaid expenses and other
    		126,000 -2,598,000 -4,363,000 -3,511,000                  
      increase in trade, income tax, accrued expenses and other payables
    		-112,193,000 52,211,000 77,287,000 -2,289,000                  
      (investment in) proceeds from marketable securities
    		             -116,986,000 -206,464,000 -275,128,000      
      realized gain on sale of long-lived assets
    		 -4,000                    
      purchase (sale) of marketable securities
    		 3,179,000  -1,855,000                  
      income from marketable securities
    		         -525,000  -310,000 -1,470,000 1,655,000 -909,000 -521,000      
      purchase of intangible assets
    		       -250,000              
      effect of change in exchange rate on marketable securities, bank deposits and inter-company balances
    		                     
      loss (income) from marketable securities
    		   1,572,000 760,000 247,000                
      effect of change in exchange rate on inter-company balances, marketable securities and bank deposits
    		    -1,841,000 -1,728,000  -4,851,000 -586,000 -5,624,000 17,147,000 -28,918,000 84,658,000         
      increase in other receivables, income tax receivable, prepaid expenses and other
    		     -3,462,000        8,402,000 -15,876,000 -21,483,000    19,612,000  
      increase in trade, income tax, accrued expenses, and other payables
    		     483,957,000                
      (sale) purchase of marketable securities
    		     -745,000                
      realized loss on sale of long-lived assets and marketable securities
    		                     
      decrease in other receivables, prepaid expenses and other
    		                     
      decrease in income tax receivables
    		                     
      proceeds from short-term bank deposits
    		          174,158,000 51,345,000 -64,471,000 4,044,000 174,911,000 46,940,000      
      proceeds from long-term deposits and other assets
    		          0 70,685,000         18,000 
      proceeds from (investment in) sale of long-lived assets
    		                     
      dividends paid
    		                     
      decrease in other receivables, income tax receivable, prepaid expenses and other
    		       5,223,000 6,513,000 15,671,000            
      (income) income from marketable securities
    		       28,000              
      sale of marketable securities
    		       19,000              
      realized gain on sale of marketable securities
    		                     
      decrease in trade, income tax, accrued expenses, and other payables
    		        10,826,000 -22,965,000 11,102,000 -17,408,000 -9,746,000  -3,962,000 -3,377,000      
      investment in the sale of plant, property & equipment
    		                     
      realized loss on sale of marketable securities and long-lived assets
    		                     
      proceeds from the sale of long-lived assets
    		                     
      realized gain on sale of marketable securities and long-lived assets
    		          25,000 -7,000 257,000 -29,000 372,000 -247,000      
      decrease (increase) in other receivables, income tax receivable, prepaid expenses and other
    		          9,472,000 52,479,000 -73,781,000     3,690,000    
      proceeds from the sale of property, plant and equipment
    		                     
      decrease (increase) in inventories
    		           2,653,000          
      impairment of long-lived assets
    		                     
      proceeds from (investment in) long-term deposits and other assets
    		             112,197,000        
      impairment for long-lived assets
    		                 0 76,000 108,000  
      effect of change in exchange rate on inter-company balances and bank deposits
    		             -4,661,000 39,486,000 22,078,000  -20,983,000 -13,135,000 4,101,000  
      (investment in) proceeds from other intangible assets
    		                     
      non-cash operating transactions:
    		                     
      sale of intangible asset
    		                     
      investment in long-term deposits and other assets
    		                 -19,824,000 -138,289,000 -143,503,000  
      cash paid during the quarter for:
    		                     
      ·
    		                     
      adjustments required to reconcile net income to net cash
    		                     
      provided by operating activities:
    		                     
      accrued severance pay and other long-term liabilities
    		                    -210,000 
      (gain) loss on sale of long-lived assets
    		                     
      realized (gain) loss on sale of marketable securities
    		                     
      foreign exchange effect of bank deposits
    		                     
      decrease in long-term debt due to currency fluctuations
    		                     
      decrease (increase) in other long-term assets
    		                     
      decrease in trade payables
    		                     
      proceeds from (investment in) other assets
    		                     
      proceeds from (investment in) short-term bank deposits
    		                -54,684,000 112,510,000 47,590,000 90,754,000 18,045,000 
      proceeds from restricted bank deposits
    		                    4,014,000 
      (investment in) proceeds from long-term deposits and other assets
    		                     
      proceeds from sale of long-lived assets
    		                    28,000 
      proceeds from issuance of shares
    		                    7,000 
      repayment of long-term debt
    		                     
      interest
    		                    216,000 
      non-cash investing and financing transactions:
    		                     
      realized (gain) loss on sale of marketable securities and long-lived assets
    		                 -8,512,000    
      decrease in trade, income tax and other payables and accrued expenses
    		                 9,189,000 -17,311,000 -3,420,000  
      proceeds from (investment in) other intangible assets
    		                     
      proceeds from other assets
    		                     
      effect of change in exchange rate on inter-company balances
    		                     
      increase in trade, income tax and other payables and accrued expenses
    		                     
      (investment in) proceeds from other intangible assets and long-lived assets
    		                     
      change in deferred charges and other assets
    		                    8,000 
      share-based compensation expense
    		                     
      loss on sale of long-lived assets
    		                    22,000 
      effect of exchange differences on inter-company balances
    		                    2,104,000 
      increase in long-term debt due to currency fluctuations
    		                    814,000 
      decrease in long-term receivables, prepaid expenses and other
    		                     
      investment in other assets
    		                     
      excess tax benefits from share-based payment arrangements
    		                     
      purchase of property, plant and equipment on credit
    		                    633,000 
      increase in long-term receivables, prepaid expenses and other
    		                     
      (investment in) proceeds from short-term bank deposits
    		                     
      proceeds from (investment in) restricted bank deposits
    		                     
      proceeds from sale of (investment in) marketable securities
    		                     
      repayment of short-term bank debt
    		                     
      proceeds from long-term debt and capital leases
    		                     
      (a) non-cash investing and financing transactions:
    		                     
      decrease in long-term receivables and other assets
    		                    53,000 
      proceeds from short-term bank debt
    		                     
      (repayment of) proceeds from long-term debt
    		                    -6,595,000 
      decrease (increase) in long-term receivables and other assets
    		                     
      (investment in) proceeds from restricted bank deposits
    		                     
      proceeds from sale (purchase) of marketable securities
    		                     
      (repayment of) proceeds from short-term bank debt
    		                     
      cash and cash equivalents at the beginning of the year
    		                     
      cash and cash equivalents at the end of the year
    		                     
      minority interest in earnings (losses) of a subsidiary
    		                     
      compensation in respect of options granted to non-employees
    		                     
      accrued severance pay
    		                     
      capital gain on sale of property, plant and equipment
    		                     
      currency fluctuation of long-term debt
    		                     
      tax benefit from exercise of options
    		                     
      increase in other accounts receivable and prepaid expenses
    		                     
      increase in income taxes payable
    		                     
      net cash provided (used in) by operating activities
    		                     
      acquisition of thames pharmacal company, inc.
    		                     
      purchase of product rights
    		                     
      long-term and other deposits
    		                     
      investment in restricted short-term bank deposits
    		                     
      proceeds from sale of property, plant and equipment
    		                     
      proceeds from exercise of options and issuance of shares of espp
    		                     
      proceeds from long-term debt
    		                     
      short-term bank credit and short-term loans
    		                     
      supplemental disclosure of cash flow transaction:
    		                     
      (a) acquisition of thames pharmacal company, inc.:
    		                     
      estimated fair value of assets acquired and liabilities assumed at the date of acquisition:
    		                     
      working capital deficiency
    		                     
      property, plant and equipment
    		                     
      intangible assets
    		                     
      goodwill
    		                     
      (b) non-cash investing and financing transactions:
    		                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.